Skip to content
CAR-TCR_Boston_2020_Final - Copy

August 31-September 2, 2021

  • Home
  • About
    • About Event
    • Who Attends
    • CAR-TCR Series
    • Meet the Team
  • What’s On
    • 2020 Full Event Guide
  • News & Media
    • Content Hub
      • Industry Insights
      • The Emily Whitehead Foundation
    • Patient’s Stories
    • Summit Photo Gallery
  • Partnership
    • Partnership Opportunities
    • Partners
    • Industry Partners
    • Media Partners
  • Get Involved
    • Register Interest
    • Contact Us

Integral Molecular

By csamuel | 5th November 2020

Integral Molecular is the industry leader in membrane protein antibody discovery, with a pipeline of therapeutic antibodies against GPCRs, ion channels, transporters, and immuno-oncology targets. Built on the company’s extensive experience optimizing membrane proteins, Integral Molecular’s technology suite enables the isolation, characterization, and engineering of MAbs against otherwise intractable targets. The company currently has therapeutic programs focused on cancer, pain, immunity, and infectious diseases.

www.integralmolecular.com/

OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com

Lost?

2020 Event Guide

Register Interest

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.